| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |